

Cover Story
COVID-19 & CancerFreeGuest Editorial
Cancer patients and survivors should not get COVID-19. A three-time cancer survivor should definitely not get COVID. But I did. And it was not good. Here is my story and the lessons I learned that might be of value to others.
In Brief


Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for Jan. 2021
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Richard Pazdur discusses root causes of cisplatin and carboplatin shortage and what can be done to alleviate it
- UCSD’s Comprehensive Cancer Center designation is in trouble; director Califano steps down amid turmoil
- Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die
- Robert Winn tells us how he led VCU Massey to obtain Comprehensive designation
- ASCO’s Julie Gralow: At least 100,000 (and up to 500,000) cancer patients affected by cisplatin, carboplatin shortage
- Sexual harassers should face consequences: As NIH director, Bertagnolli can foster change